Background: Surgery for secondary mitral regurgitation is still controversial, especially when the left ventricle is damaged. The Mitra Clip has been shown to be safe and effective for certain patient groups but does not offer superior control of mitral regurgitation compared with the surgery. If performed safely, the surgery can provide greater benefits over the long-term. The objective of this study was to retrospectively investigate the early and long-term results of mitral valve surgery for secondary mitral valve regurgitation with a damaged, dilated left ventricle.
mitral valve regurgitation is still controversial, especially when the left ventricle is enlarged and damaged. [5] [6] [7] [8] [9] [10] [11] [12] [13] The controversy results from the fact that secondary mitral valve regurgitation results from an already damaged left ventricle and surgical correction of the regurgitation cannot address the pre-existing left ventricular damage. 3, 13 However, in ischemic mitral valve regurgitation as a form of secondary mitral valve regurgitation, the presence of even moderate mitral regurgitation is associated with a worsened prognosis. 8, 9 Correction of secondary mitral regurgitation is likely to be beneficial, although clear evidence remains lacking.
The Mitra Clip (Abbott Vascular, Menlo Park, CA) has been proven safe and effective for a certain subset of patients but does not seem to offer superior control of mitral regurgitation as compared with the surgery. 14 The purpose of this study was to retrospectively investigate the operative and long-term results of mitral valve surgery for secondary mitral valve regurgitation with dilated reduced left ventricular function and to identify predictors of rehospitalization because of heart failure and death after mitral valve surgery.
| PATIENTS AND METHODS
Between November 2008 to October 2018, all cases of cardiac surgery performed at Nagoya Heart Center were screened and patients with preoperative echocardiographic ejection fraction <40%, left ventricular end-diastolic diameter >50 mm and end-systolic diameter >40 mm were identified. Of these, cases that underwent mitral valve surgery for secondary mitral valve regurgitation without the aortic valve procedure comprised the study group. Concerning echocardiographic evaluations, the dimensions of the cardiac chamber were measured using the standard M-mode method. The cardiac ejection fraction was calculated using the modified Simpson's method. Valve regurgitation was assessed using color-flow Doppler as "trivial", "mild", "moderate", or "severe". Postoperative transthoracic echography was performed on each patient before discharge.
Chronic obstructive pulmonary disease was defined as the percentage predicted forced expiratory volume in 1.0 seconds less than 75%, partial pressure of oxygen in arterial blood less than 60 mm Hg or provision of medical therapy. Liver dysfunction was defined as total bilirubin greater than 1.5 mg/dL or liver enzymes (aspartate aminotransferase or alanine aminotransaminase) greater than 100 U/L. Clinical data were gathered from medical records, operative records or the in-hospital surgical database.
Long-term results were assessed by direct contact or telephone interviews with patients, their families, or local doctors. Survival was assessed from April to October 2018.
The primary end-points were mortality and morbidity as early results, and mortality and hospitalization because of heart failure as long-term results. As sub-analyses, differences in results were assessed between mitral repair and replacement groups. We also investigated risk factors for mortality and hospitalization.
The data were analyzed using the SPSS version 22 statistical software (SPSS, Chicago, IL). Results are expressed as mean ± standard deviation. Continuous data were analyzed using the Mann-Whitney U test or t test as appropriate. Categorical data were analyzed using the χ 2 test. Multivariate analyses were performed using multiple logistic regression analysis with a forcible loading method. Survival analysis was performed using the Kaplan-Meier method. Results were considered to be significant for values of P < .05. Our strategy for selecting repair or replacement was changed at the beginning of 2014, on the basis of the results of a randomized control study and the favorable results of chordal-sparing mitral valve replacement. 15, 16 Before 2014, our first choice of mitral procedure was mitral plasty even in cases with reduced cardiac function. Mitral valve replacement was chosen when the leftventricular diastolic diameter was greater than 70 mm, in redo cases, or in hemodialysis cases for which reverse remodeling was not expected. Since 2014, we have selected chordal-sparing mitral valve replacement as the first-line procedure in secondary mitral regurgitation with a damaged heart. Mitral plasty was applied in younger patients (early 60 s or younger), and the left-ventricular diastolic diameter was less than 60 mm.
| Operative procedures and strategy
Apart from this strategy, we have chosen mitral valve replacement for all patients for whom poor prognosis was anticipated, such as in patients with advanced age, fragility, or other critical illness.
In mitral valve plasty, an undersized annuloplasty full ring was used and whether or not the mitral sub-valvular apparatus procedure was performed was determined by the surgeon based on the findings from echocardiography, such as tethering height greater than 10 mm 17 or location of papillary muscles. Our sub-apparatus procedures consist of papillary muscle resuspension to the mitral anterior annulus with CV4. When the papillary muscle heads were separated, the anterior and posterior heads were combined together with the resuspension stitch, then re-suspended as previously reported. 18 In mitral valve replacement, mitral leaflets were tucked in the annulus with stitches securing the prosthetic valve, and all chordae were preserved. This study was approved by the institutional ethics committee, and the need to obtain written consent from patients was waived because of the retrospective study design.
| RESULTS
During the observation period, 2306 cases of cardiac surgery were performed in our institution and 226 cases were identified as showing dilated, reduced left the ventricular function. Of these, 86 cases underwent mitral valve surgery without the aortic valve procedure. Six cases were excluded from the analysis, because of primary (organic) mitral valve regurgitation in three cases and congenitally corrected transposition of the great arteries in three cases. As a result, 80 cases comprised the study group and were investigated for early and longterm results. Preoperative characteristics of these 80 patients are shown in Table 1 . Mean age of the 80 patients at the time of operation was 65.7 years, and 63 patients were male. Preoperative echocardiograms showed a severely dilated and damaged left ventricle, with a mean ejection fraction of 25.2%, and left ventricular diameters in diastole/systole of 64.5/56.9 mm, respectively.
In all but one case, who underwent surgery through a right thoracotomy under hypothermic ventricular fibrillation because severe adhesions were anticipated because of previous cardiac surgery, procedures were performed through median sternotomy.
Perioperative results are shown in Table 2 . Mitral valve replacement was performed in 39 cases, and mitral valve plasty in 41 cases.
Among the cases of mitral valve plasty, 29 cases received subvalvular apparatus procedures. The most common concomitant procedures were coronary artery bypass grafting and tricuspid valve surgery (41.3% each). The Maze procedure was performed in 28.8% of cases.
The mean operation time was 292.9 minutes, and the mean aortic cross-clamp time was 90.7 minutes. Transfusion was performed in 58 cases (72.5%).
One patient required prolonged Postoperative ventilation (>24 hours), but postoperative morbidity rates were relatively low, except for atrial fibrillation (40%). No cases of 30-day/in-hospital death were encountered and the mean duration of hospitalization from operation to discharge was 21.9 days.
Postoperative echocardiograms showed significantly improved mitral regurgitation from 3.5 (moderate to severe) to 0.83 (less than trivial, P = .000).
As a sub-analysis, we divided patients into two groups: a repair group, and a replacement group. (Table 4 ). Postoperative results did not differ between groups.
The rate of a successful collection of follow-up data was 98.8%, with a mean follow-up of 1264 days (range, 19-3630 days). Figure 1 shows the survival curve for all-cause death. Actual 1-, 3-and 5-year survival rates were 93.1%, 80.0%, and 64.7%, respectively. Figure 2 demonstrates the survival curve for cardiac death, including sudden death, death from unknown cause, and cerebral infarction. Deaths from pneumonia (two cases) and cancer (two cases) were regarded as noncardiac deaths. The 1-, 3-, and 5-year survival rates were 93.1%, 81.3%, and 68.6%, respectively. Figure 3 shows the rate of freedom from Readmission because of heart failure. The 1-, 3-, and 5-year readmission-free rates were 82.6%, 68.4%, and 53.7%, respectively. Table 5 indicates factor analyses for all-cause death and readmission because of heart failure. When multivariate analyses were performed, age was identified as an independent risk factor for allcause death, and the left atrial dimension was significantly associated with postoperative heart failure.
Neither the mitral valve procedure nor etiology affected the longterm outcomes in this study.
| DISCUSSION
This was a single-center, retrospective report of the early and long- this study were excellent in terms of surgical mortality and good in terms of perioperative complications.
Long-term survival in this study was acceptable when considering the previous reports, in which the long-term results for secondary mitral valve regurgitation were dismal when only pharmacotherapy was provided. 19, 20 Feldman et al 1 In this study, we applied both mitral repair and replacement.
However, we chose valve replacement for more severe patients. As mitral valve replacement has been shown to require shorter operative, perfusion, and cross-clamp times, our strategy might contribute to good early results.
Although the postoperative morbidity rate was low, postoperative hospitalization was long, at almost 22 days. This is because patients with poor cardiac function show slow recovery and require a longer time to achieve optimal regimens for medications, such as angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers or beta-blockers. The left atrial diameter was the only predictor of postoperative heart failure in the present study. Although we did not assess pulmonary artery pressure in this study, the left atrial diameter has been reported to be independently associated with pulmonary artery systolic pressure. 21 Our results suggest that patients who require readmission after mitral valve surgery have higher pulmonary artery pressure than those not hospitalized after surgery. Note: Values represent number (%) or mean ± SD. Abbreviations: COPD, chronic obstructive pulmonary disease; SD, standard deviation.
